TY - JOUR
T1 - Cheap and rapid in-house method for direct identification of positive blood cultures by MALDI-TOF MS technology
AU - Azrad, Maya
AU - Keness, Yoram
AU - Nitzan, Orna
AU - Pastukh, Nina
AU - Tkhawkho, Linda
AU - Freidus, Victoria
AU - Peretz, Avi
N1 - Publisher Copyright:
© 2019 The Author(s).
PY - 2019/1/18
Y1 - 2019/1/18
N2 - Background: Rapid and accurate pathogen identification in blood cultures is very important for septic patients and has major consequences on morbidity and mortality rates. In recent years, matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS)-based technology has become useful for highly specific and sensitive identification of bacteria and yeasts from clinical samples including sterile body fluids. Additional in-house methods enabled direct identification from blood cultures following various preparation protocols. Methods: Blood culture (5 ml) was harvested from each positive bottle following growth identification by BACTEC™ FX system and transferred into a VACUETTE® Z Serum Sep Clot Activator tube containing an inert gel, which following centrifugation separates microorganisms from the blood cells. We used MALDI-TOF MS analysis for identification of microorganisms collected from the gel surface. Results: Positive blood culture bottles (186) were collected. In comparison with the routine method, 99% (184/186) and 90% (168/186) of the isolates were correctly identified by the SepsiTyper kit and the in-house method, respectively. We found high concordance (Pearson coefficient = 0.7, p < 0.0001) between our in-house method and the SepsiTyper kit. Additionally, high correlation was found in sub-groups of identified bacteria, with Pearson coefficients of 0.77 (p < 0.0001), 0.67 (p < 0.0001), and 0.73 (p < 0.007) for Gram negative, Gram positive, and anaerobic bacteria, respectively. Conclusions: Our in-house method was found to be in good agreement with the SepsiTyper kit. Considering the low costs and the rapid and easy implementation of this procedure, we propose our in-house method for the direct identification of bacteria from blood cultures.
AB - Background: Rapid and accurate pathogen identification in blood cultures is very important for septic patients and has major consequences on morbidity and mortality rates. In recent years, matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS)-based technology has become useful for highly specific and sensitive identification of bacteria and yeasts from clinical samples including sterile body fluids. Additional in-house methods enabled direct identification from blood cultures following various preparation protocols. Methods: Blood culture (5 ml) was harvested from each positive bottle following growth identification by BACTEC™ FX system and transferred into a VACUETTE® Z Serum Sep Clot Activator tube containing an inert gel, which following centrifugation separates microorganisms from the blood cells. We used MALDI-TOF MS analysis for identification of microorganisms collected from the gel surface. Results: Positive blood culture bottles (186) were collected. In comparison with the routine method, 99% (184/186) and 90% (168/186) of the isolates were correctly identified by the SepsiTyper kit and the in-house method, respectively. We found high concordance (Pearson coefficient = 0.7, p < 0.0001) between our in-house method and the SepsiTyper kit. Additionally, high correlation was found in sub-groups of identified bacteria, with Pearson coefficients of 0.77 (p < 0.0001), 0.67 (p < 0.0001), and 0.73 (p < 0.007) for Gram negative, Gram positive, and anaerobic bacteria, respectively. Conclusions: Our in-house method was found to be in good agreement with the SepsiTyper kit. Considering the low costs and the rapid and easy implementation of this procedure, we propose our in-house method for the direct identification of bacteria from blood cultures.
KW - BACTEC™ FX system
KW - Bacteria
KW - Blood culture
KW - MALDI-TOF MS
KW - SepsiTyper kit
UR - http://www.scopus.com/inward/record.url?scp=85060146618&partnerID=8YFLogxK
U2 - 10.1186/s12879-019-3709-9
DO - 10.1186/s12879-019-3709-9
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 30658585
AN - SCOPUS:85060146618
SN - 1471-2334
VL - 19
JO - BMC Infectious Diseases
JF - BMC Infectious Diseases
IS - 1
M1 - 72
ER -